WO2023235666A3 - Human antibodies to bordetella pertussis and uses therefor - Google Patents
Human antibodies to bordetella pertussis and uses therefor Download PDFInfo
- Publication number
- WO2023235666A3 WO2023235666A3 PCT/US2023/067387 US2023067387W WO2023235666A3 WO 2023235666 A3 WO2023235666 A3 WO 2023235666A3 US 2023067387 W US2023067387 W US 2023067387W WO 2023235666 A3 WO2023235666 A3 WO 2023235666A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bordetella pertussis
- human antibodies
- uses therefor
- therefor
- bordetella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1225—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Bordetella (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/235—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bordetella (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present disclosure is directed to antibodies binding to Bordetella pertussis toxin and methods for use therefor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263347175P | 2022-05-31 | 2022-05-31 | |
| US63/347,175 | 2022-05-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2023235666A2 WO2023235666A2 (en) | 2023-12-07 |
| WO2023235666A3 true WO2023235666A3 (en) | 2024-01-11 |
Family
ID=89025642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2023/067387 Ceased WO2023235666A2 (en) | 2022-05-31 | 2023-05-24 | Human antibodies to bordetella pertussis and uses therefor |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2023235666A2 (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150902A1 (en) * | 2008-04-11 | 2010-06-17 | Jean-Francois Haeuw | Anti-cd151 antibodies and their use in the treatment of cancer |
| US20180256699A1 (en) * | 2014-12-08 | 2018-09-13 | Board Of Regents, The University Of Texas System | Bordetella adenylate cyclase toxin vaccines and neutralizing antibodies |
| US20190367616A1 (en) * | 2016-11-18 | 2019-12-05 | Symphogen A/S | Anti-PD-1 Antibodies and Compositions |
| WO2020223573A2 (en) * | 2019-04-30 | 2020-11-05 | Gigagen, Inc. | Recombinant polyclonal proteins and methods of use thereof |
| US20210214420A1 (en) * | 2018-06-18 | 2021-07-15 | Dxdiscovery Inc. | Methods and compositions for pertussis diagnosis |
| CN114106171A (en) * | 2020-12-21 | 2022-03-01 | 天士力生物医药股份有限公司 | anti-AQP 4 antibodies and uses thereof |
-
2023
- 2023-05-24 WO PCT/US2023/067387 patent/WO2023235666A2/en not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150902A1 (en) * | 2008-04-11 | 2010-06-17 | Jean-Francois Haeuw | Anti-cd151 antibodies and their use in the treatment of cancer |
| US20180256699A1 (en) * | 2014-12-08 | 2018-09-13 | Board Of Regents, The University Of Texas System | Bordetella adenylate cyclase toxin vaccines and neutralizing antibodies |
| US20190367616A1 (en) * | 2016-11-18 | 2019-12-05 | Symphogen A/S | Anti-PD-1 Antibodies and Compositions |
| US20210214420A1 (en) * | 2018-06-18 | 2021-07-15 | Dxdiscovery Inc. | Methods and compositions for pertussis diagnosis |
| WO2020223573A2 (en) * | 2019-04-30 | 2020-11-05 | Gigagen, Inc. | Recombinant polyclonal proteins and methods of use thereof |
| CN114106171A (en) * | 2020-12-21 | 2022-03-01 | 天士力生物医药股份有限公司 | anti-AQP 4 antibodies and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| DATABASE UNIPROTKB ANONYMOUS : "A0A0R3KTY0 · A0A0R3KTY0_9BRAD", XP093128306, retrieved from UNIPROT * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023235666A2 (en) | 2023-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4356924A3 (en) | Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2) | |
| EP0077734A3 (en) | Production of monoclonal antibodies against bacterial adhesins | |
| NZ568769A (en) | Human monoclonal antibodies against CD20 | |
| NO974371D0 (en) | Epithelial adhesive lactobacilli | |
| YU28503A (en) | Humanized anti-lt-betha-r antibodies | |
| ATE546516T1 (en) | LACTOBACILLUS PLANTARUM STRAINS IN COMBINATION WITH TANNIN COMPREHENSIVE COMPOSITIONS AS WELL AS NEW LACTOBACILLUS PLANTARUM STRAINS | |
| DE60026691D1 (en) | STAPHYLOCOCCUS ANTIGENES AND IMPREGENTS | |
| AU9536898A (en) | 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein | |
| NO972922L (en) | Preparations and methods to reduce skin irritation | |
| TW200500377A (en) | Method of humanizing immune system molecules | |
| ATE301471T1 (en) | USE OF ANTIBODIES AGAINST CD45RO LEUKOCYTE ANTIGEN FOR IMMUNE MODULATION | |
| YU101503A (en) | A novel engineered superantigen for human therapy | |
| MX9807348A (en) | Sunless tanning composition and method | |
| WO2021216667A3 (en) | Antibodies to chitinase 3-like-1 and methods of use therefor | |
| WO2004031105A3 (en) | Use of a33 antigens and jam-it | |
| EP0135073A3 (en) | Antigens and monoclonal antibodies reactive against merozites of eimeria spp. | |
| WO2021195385A8 (en) | HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) | |
| WO2024163630A3 (en) | Anti-cdh17 antibodies and use of the same | |
| HK21795A (en) | Cross-protective human monoclonal antibody compositions | |
| WO2023235666A3 (en) | Human antibodies to bordetella pertussis and uses therefor | |
| DE60214495D1 (en) | A hair treatment cosmetic composition containing a hair-fixing non-associative polyurethane and an anionic or nonionic associative polyurethane, and a cosmetic treatment method | |
| PT812206E (en) | LIGACAO PROTEIN TO CD40 FOR STIMULATION OF AN IMMUNE RESPONSE | |
| AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
| EA200701092A1 (en) | Interleukin-21 antigen epitopes, associated antibodies and their use in medicine. | |
| IL323375A (en) | Antibody specifically binding to claudin18.2 and preparation method therefor and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23816850 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 23816850 Country of ref document: EP Kind code of ref document: A2 |